Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis. The Company’s lead asset is being developed for the treatment of ATTR cardiomyopathy, a serious and progressive form of amyloidosis. Immutrin's antibody is a potential best-in-class therapy, with a unique mechanism of action designed to selectively and exclusively remove established amyloid fibrils.
| Website | https://www.immutrin.com/ |
| Employees | 19 (11 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Immutrin employee's phone or email?
Immutrin Questions
Mihriban Tuna is the CEO of Immutrin.
11 people are employed at Immutrin.
Immutrin is based in Cambridge, England.
Top Immutrin Employees
-
Mihriban Tuna
Chief Executive Officer at Immutrin
United Kingdom2 -
Tolga Hassan
Chief Financial Officer at Immutrin
Cambridge, GB1 -
Oliver Schon
VP, CMC Development at Immutrin
Cambridge, GB3 -
Ali Murad
Vice President Clinical Development at Immutrin
London, England, GB14 -
Robert Blaustein
Chief Medical Officer at Immutrin
Westfield, NJ, US25+ -
Kimmy Leung
VP, Head of R and D at Immutrin
United Kingdom1 -
Shobhal Patel
Vice President Clinical Operations at Immutrin
Newport Beach, CA, US14 -
Pauline Stevens
Operations Director at Immutrin
United Kingdom11 -
Bob Gabel
Sr. Director, Program Management at Immutrin
Harleysville, PA, US15+ -
Jack Wade
Principal Scientist at Immutrin
United Kingdom11
G2Crowd Trusted
300K+
Plugin Users
